RAPP 8-K 2026-10-30

Rapport Therapeutics, Inc. (RAPP) 8-K dated 2026-10-30 — accession 0001193125-26-441851. This URL is the filing, not the RAPP hub.

Rapport Therapeutics, Inc. (RAPP) is a biotechnology company listed on US.

RAPP to acquire platform ($215.7M)

Cached items: 1.01, 2.02, 2.03, 3.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RAPP revenue for 2026-06-30 was $0. Net income was -$56.6M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. RAPP currently screens at market cap $532.9M.

Not investment advice. The RAPP SEC hub lists recent forms. The stock page is the research view.